Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04828083 · ClinicalTrials.gov registry record · Phase 4
Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty
A Phase 4 study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT04828083 is a Phase 4 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 120 participants.
The verdict
NCT04828083, a Phase 4 study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
The investigators are evaluating the postoperative outcomes in patients undergoing total knee arthroplasty that receive either systemic lidocaine or ultrasound-guided adductor canal block as part of their anesthetic plan.
Interventions
- DRUG Lidocaine IV
- DRUG Saline IV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2024-09-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04828083
The ClinicalTrials.gov registry entry for NCT04828083 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine IV is the first listed.
NCT04828083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04828083 about?
NCT04828083 is a clinical study titled "Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty". The investigators are evaluating the postoperative outcomes in patients undergoing total knee arthroplasty that receive either systemic lidocaine or ultrasound-guided adductor canal block as part of their anesthetic plan.
What is the current status of trial NCT04828083?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2021-03-01. Estimated completion is 2024-09-02.
What interventions are being tested in trial NCT04828083?
The interventions under investigation include: Lidocaine IV (DRUG), Saline IV (DRUG).
Who is sponsoring clinical trial NCT04828083?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.